# AsimicA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/asimica

- Industry: Biotechnology
- Headquarters: Laramie, US
- Website: www.asimica.com
- Latest round: Seed (Aug 27, 2020)
- Investors on record: 2

## About

AsimicA, Inc. is a healthcare technology company focused on delivering innovative data analytics and digital health platforms to improve patient management and clinical workflows for healthcare providers.AsimicA, Inc. specializes in healthcare technology solutions based in Laramie, US. Founded in 2018 by Jacob Guidry, the company has undergone significant development focused on enhancing healthcare operational efficiencies. Nikolai Mushnikov currently serves as the CEO. AsimicA raised seed funding from SOSV and IndieBio in August 2020, marking its first investment round, and has completed one deal since its inception.AsimicA specializes in providing innovative solutions tailored for the healthcare sector, focusing primarily on advanced data analytics and digital health platforms. Their core offerings encompass a suite of software applications designed to facilitate patient management, enhance clinical workflows, and improve decision-making processes for healthcare professionals. These products aim to address critical challenges such as streamlining patient care, reducing operational inefficiencies, and optimizing resource allocation within medical facilities. Asimica's client base includes hospitals, clinics, and healthcare providers across North America and Europe, where they serve end-users ranging from healthcare administrators to medical practitioners. The solutions have been released progressively over the past few years, gaining traction in markets that prioritize the integration of technology in healthcare.Asimica's revenue structure is primarily based on subscription models for its software solutions, allowing healthcare organizations to access their platforms on a recurring basis. Clients typically engage in annual or multi-year contracts, facilitating predictable revenue streams for the company. The transaction framework includes tiered pricing plans that cater to different organizational sizes and needs, encompassing a range of services from basic access to comprehensive packages that include premium support and advanced analytics tools. Revenue is generated through direct sales to healthcare institutions, ensuring that end-users can efficiently integrate Asimica's offerings into their existing systems. Flagship products, which are central to the company's portfolio, are designed to deliver measurable outcomes, further reinforcing their value proposition in the competitive healthcare technology market.AsimicA is focused on developing new products aimed at enhancing patient care management, with launches expected in the next 12 months. The company plans to expand its market presence in Asia and South America, targeting deployment by the end of 2023. The seed funding raised in August 2020 will be directed towards accelerating product development and market entry initiatives.

## Funding rounds

- Seed, Aug 27, 2020 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed